Management of Acute ILD Exacerbation (AE-IPF): Does Rituximab Provide Beneficial Effects for IPF Patients? What Is the Efficacy of Autoantibody Reduction Therapies?

667 views
February 2, 2021
1 Comment
Login to view comments. Click here to Login